Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

242 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Iron is a modifier of the phenotypes of JAK2-mutant myeloproliferative neoplasms.
Stetka J, Usart M, Kubovcakova L, Rai S, Rao TN, Sutter J, Hao-Shen H, Dirnhofer S, Geier F, Bader MS, Passweg JR, Manolova V, Dürrenberger F, Ahmed N, Schroeder T, Ganz T, Nemeth E, Silvestri L, Nai A, Camaschella C, Skoda RC. Stetka J, et al. Among authors: passweg jr. Blood. 2023 Apr 27;141(17):2127-2140. doi: 10.1182/blood.2022017976. Blood. 2023. PMID: 36758212 Free article.
Minimal residual disease monitoring by Ig/TCR gene rearrangements predicts post-transplant relapse and survival in adult patients with acute lymphoblastic leukemia.
Bader MS, Kubetzko S, Schäfer BW, Arranto C, Drexler B, Halter J, Passweg JR, Medinger M. Bader MS, et al. Among authors: passweg jr. Ann Hematol. 2024 Nov;103(11):4831-4833. doi: 10.1007/s00277-024-05943-1. Epub 2024 Aug 21. Ann Hematol. 2024. PMID: 39167183 Free PMC article. No abstract available.
Technical comment on: Trottmann M, et al. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data.
Arber C, Baerlocher G, Chalandon Y, Daskalakis M, Duchosal M, Fehr M, Gerull S, Güngör T, Nair G, Pabst T, Passweg JR, Piccolruaz B, Renner C, Ruefer A, Schneidawind D, Stüssi G, Zeerleder S, Halter JP; Swiss Blood Stem Cell Transplant and Cellular Therapies (SBST) group. Arber C, et al. Among authors: passweg jr. Swiss Med Wkly. 2024 Oct 3;154:3704. doi: 10.57187/s.3704. Swiss Med Wkly. 2024. PMID: 39463445 Free article. No abstract available.
CD4+ CAR T-cell expansion is associated with response and therapy related toxicities in patients with B-cell lymphomas.
Baur K, Buser A, Jeker LT, Khanna N, Läubli H, Heim D, Dirks JC, Widmer CC, Volken T, Passweg JR, Holbro A. Baur K, et al. Among authors: passweg jr. Bone Marrow Transplant. 2023 Sep;58(9):1048-1050. doi: 10.1038/s41409-023-02016-1. Epub 2023 Jun 17. Bone Marrow Transplant. 2023. PMID: 37330601 Free PMC article. No abstract available.
Post-transplant Inflammatory Bowel Disease Associated with Donor-Derived TIM-3 Deficiency.
Baldrich A, Althaus D, Menter T, Hirsiger JR, Köppen J, Hupfer R, Juskevicius D, Konantz M, Bosch A, Drexler B, Gerull S, Ghosh A, Meyer BJ, Jauch A, Pini K, Poletti F, Berkemeier CM, Heijnen I, Panne I, Cavelti-Weder C, Niess JH, Dixon K, Daikeler T, Hartmann K, Hess C, Halter J, Passweg J, Navarini AA, Yamamoto H, Berger CT, Recher M, Hruz P. Baldrich A, et al. Among authors: passweg j. J Clin Immunol. 2024 Feb 16;44(3):63. doi: 10.1007/s10875-024-01667-z. J Clin Immunol. 2024. PMID: 38363399 Free PMC article.
242 results